References
- De Ziegler D, Streuli I, Meldrum DR, et al. The value of growth hormone supplements in ART for poor ovarian responders. Fertil Steril. 2011;96:1069–1076.
- Kyrou D, Kolibianakis EM, Venetis CA, et al. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril. 2009;91:749–766.
- Kolibianakis EM, Venetis CA, Diedrich K, et al. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2009;15:613–622.
- Brinsden, Mills CL, editors. Factors affecting embryological parameters and embryo selection for IVF-ET. A Textbook of in vitro fertilization and assisted reproduction. 1992;187–204.
- Tesarik J, Hazout A, Mendoza C. Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone. Hum Reprod. 2005;20:2536–2541.
- Owen EJ, West C, Mason BA, et al. Co-treatment with growth hormone of sub-optimal responders in IVF-ET. Hum Reprod. 1991;6:524–528.
- Choe SA, Kim MJ, Lee HJ, et al. Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study. Arch Gynecol Obstet. 2018;297:791–796.
- Homburg R, Eshel A, Abdalla HI, et al. Growth hormone facilitates ovulation induction by gonadotrophins. Clin Endocrinol (Oxf). 1988;29:113–117.
- Lessey BA, Castelbaum AJ, Sawin SW, et al. Integrins as markers of uterine receptivity in women with primary unexplained infertility. Fertil Steril. 1995;63:535–542.
- Giampietro A, Milardi D, Bianchi A, et al. The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature. Fertil Steril. 2009;91:930.e937–911.
- Drakopoulos P, Pluchino N, Bischof P, et al. Effect of growth hormone on endometrial thickness and fertility outcome in the treatment of women with panhypopituitarism: a case report. J Reprod Med. 2016;61:78–82.
- Chen Y, Liu F, Nong Y, et al. Clinical efficacy and mechanism of growth hormone action in patients experiencing repeat implantation failure. Can J Physiol Pharmacol. 2018;96:929–932.
- McGrath M, Lee IM, Buring J, et al. Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk. Gynecol Oncol. 2011;120:174–178.
- Barnard R, Bundesen PG, Rylatt DB, et al. Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor. Biochem J. 1985;231:459–468.
- Mendoza C, Ruiz-Requena E, Ortega E, et al. Follicular fluid markers of oocyte developmental potential. Hum Reprod. 2002;17:1017–1022.
- Keane KN, Yovich JL, Hamidi A, et al. Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis. BMJ Open. 2017;7:e018107.